| Date Filed | Type | Description |
| 03/10/2023 |
4
| Marek David C (Principal Executive Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 95,675 shares
@ $0
Disposed/sold 321,924 shares
@ $0
Disposed/sold 306,427 options to buy
@ $20.54, valued at
$6.3M
Disposed/sold 208,218 options to buy
@ $17.88, valued at
$3.7M
Disposed/sold 204,808 options to buy
@ $11.33, valued at
$2.3M
Disposed/sold 134,567 rights
@ $0 |
|
| 01/20/2023 |
4
| Marek David C (Principal Executive Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 8,037 shares
@ $26.89, valued at
$216.1k
|
|
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2022 |
4
| Marek David C (Principal Executive Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 24,594 shares
@ $10.45, valued at
$257k
|
|
| 04/19/2022 |
4
| Marek David C (Principal Executive Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 134,567 shares
@ $0
Granted 204,808 options to buy
@ $11.33, valued at
$2.3M
|
|
| 01/21/2022 |
4
| Marek David C (Principal Executive Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 19,882 shares
@ $14.68, valued at
$291.9k
|
|
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2019 |
4
| Marek David C (Chief Commercial Officer) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 25,813 options to buy
@ $17.61, valued at
$454.6k
|
|
| 09/06/2019 |
4
| Marek David C (Chief Commercial Officer) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $24.28, valued at
$3M
|
|
| 09/06/2019 |
3
| Marek David C (Chief Commercial Officer) has filed a Form 3 on Axsome Therapeutics, Inc. |
| 09/06/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |